Roderick Chandler, MD
Orthopaedic Surgery · Mandeville, LANPI 1740226802
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Johnson & Johnson at 51.7% of the total. Reporting peaked in 2020 at $466 and has fallen 69.2% since, to $144 in 2024. That places this record below the midpoint for orthopaedic surgery clinicians in LA, where the typical reported total is $3,274.
Across 25 payments — averaging $66.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$862
- Stryker$500
- Smith+Nephew$133
- Vericel Corporation$100
- ALON Medical Technology$53
- Pacira Therapeutics, Inc.$18
What the payments were for
- Food & beverage$1,666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $862 |
| Stryker | 11 | $500 |
| Smith+Nephew | 2 | $133 |
| Vericel Corporation | 1 | $100 |
| ALON Medical Technology | 2 | $53 |
| Pacira Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,666 in reported general payments places this provider in the 35th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 183 | $1,573 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 63 | $945 |
| Celecoxib | 46 | $838 |
| Meloxicam | 240 | $642 |
| Methylprednisolone | 42 | $273 |
| Nabumetone | 22 | $239 |
| Cephalexin | 28 | $110 |
| Tramadol Hcl | 32 | $90 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mandeville
- Christopher HarrodBaton Rouge$3M
- Vinod DasaKenner$1.9M
- Pierce NunleyShreveport$1.8M
- Jorge IsazaBaton Rouge$1.2M
- Neil MakiThibodaux$620K
- Robert ZuraNew Orleans$597K
- Kevin McCarthyBaton Rouge$594K
- Timmothy RandellAlexandria$498K
- Fernando SanchezNew Orleans$484K
- Robert EastonBaton Rouge$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.